A randomized controlled study of iron supplementation in patients treated with erythropoietin

375Citations
Citations of this article
74Readers
Mendeley users who have this article in their library.

Abstract

In view of current uncertainty regarding the optimum route for iron supplementation in patients receiving recombinant human erythropoietin (EPO), a prospective randomized controlled study was designed to investigate this issue. All iron-replete renal failure patients commencing EPO who had a hemoglobin concentration < 8.5 g/dl and an initial serum ferritin level of 100 to 800 μg/liter were randomized into three groups with different iron supplementation: Group 1, i.v. iron dextran 5 ml every 2 weeks; Group 2, oral ferrous sulphate 200 mg tds; Group 3, no iron. All patients were treated with 25 U/kg of EPO thrice weekly subcutaneously. The hemoglobin concentration, reticulocyte count, serum ferritin, transferrin saturation, and EPO dose were monitored every two weeks for the first four months. Thirty-seven patients entered the study (12 i.v., 13 oral, 12 no iron). The three groups were equivalent with regard to age, sex, and other demographic details. Even allowing for dosage adjustments, the hemoglobin response in the group receiving i.v. iron (7.3 ± 0.8 to 11.9 ± 1.2 g/dl) was significantly greater than that for the other two groups (7.2 ± 1.1 to 10.2 ± 1.4 g/dl and 7.3 ± 0.8 to 9.9 ± 1.6 g/dl for Groups 2 and 3, respectively; P < 0.005 for both groups vs. Group 1 at 16 weeks). There was no difference between the groups supplemented with oral iron and no iron. Serum ferritin levels remained constant in those receiving i.v. iron (345 ± 273 to 359 ± 140 μg/liter), in contrast to the other two groups in which ferritin levels fell significantly (309 ± 218 to 116 ± 87 μg/liter and 458 ± 206 to 131 ± 121 μg/liter for Groups 2 and 3, respectively; P < 0.0005 for Group 1 vs. Group 2, and P < 0.005 for Group 1 vs. Group 3 at 16 weeks). Dosage requirements of EPO were less in Group 1 (1202 ± 229 I/kg/16 weeks) than in Group 2 (1294 ± 314 U/kg/16 weeks) or Group 3 (1475 ± 311 U/kg/16 weeks; P < 0.05 vs. Group 1). The results of this study suggest that, even in iron-replete patients, those supplemented with i.v. iron have an enhanced hemoglobin response to EPO with better maintenance of iron stores and lower dosage requirements of EPO, compared with those patients receiving oral iron and no iron supplementation.

References Powered by Scopus

Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin

1883Citations
N/AReaders
Get full text

Detection of functional iron deficiency during erythropoietin treatment: A new approach

270Citations
N/AReaders
Get full text

The diagnosis of iron deficiency anemia

268Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Kidney disease: Improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guideline for anemia in chronic kidney disease

859Citations
N/AReaders
Get full text

Mechanisms of anemia in CKD

747Citations
N/AReaders
Get full text

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

663Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Macdougall, I. C., Tucker, B., Thompson, J., Tomson, C. R. V., Baker, L. R. I., & Raine, A. E. G. (1996). A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney International, 50(5), 1694–1699. https://doi.org/10.1038/ki.1996.487

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 17

53%

Professor / Associate Prof. 8

25%

Researcher 5

16%

Lecturer / Post doc 2

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 29

66%

Pharmacology, Toxicology and Pharmaceut... 5

11%

Nursing and Health Professions 5

11%

Biochemistry, Genetics and Molecular Bi... 5

11%

Article Metrics

Tooltip
Mentions
References: 3

Save time finding and organizing research with Mendeley

Sign up for free